Reaffirming EPS guidance, especially when it aligns with consensus estimates, typically instills confidence among investors regarding the company's financial health and future performance. This announcement from HCA Healthcare is likely to have a positive impact on its stock price in the short term as it reassures investors of the company's stability and growth prospects.